These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 23306790)
1. Verrucarin A enhances TRAIL-induced apoptosis via NF-κB-mediated Fas overexpression. Jayasooriya RG; Moon DO; Yun SG; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY Food Chem Toxicol; 2013 May; 55():1-7. PubMed ID: 23306790 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells. Jennewein C; Karl S; Baumann B; Micheau O; Debatin KM; Fulda S Oncogene; 2012 Mar; 31(11):1468-74. PubMed ID: 21822306 [TBL] [Abstract][Full Text] [Related]
3. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner. Moon DO; Asami Y; Long H; Jang JH; Bae EY; Kim BY; Choi YH; Kang CH; Ahn JS; Kim GY Toxicol In Vitro; 2013 Feb; 27(1):257-63. PubMed ID: 22982206 [TBL] [Abstract][Full Text] [Related]
4. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027 [TBL] [Abstract][Full Text] [Related]
5. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X; Kandasamy K; Srivastava RK Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723 [TBL] [Abstract][Full Text] [Related]
6. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas. Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311 [TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868 [TBL] [Abstract][Full Text] [Related]
8. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells. Hermisson M; Weller M Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082 [TBL] [Abstract][Full Text] [Related]
9. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis. Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388 [TBL] [Abstract][Full Text] [Related]
10. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis. Kim HS; Chang I; Kim JY; Choi KH; Lee MS Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612 [TBL] [Abstract][Full Text] [Related]
11. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells. Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709 [TBL] [Abstract][Full Text] [Related]
13. CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Trauzold A; Wermann H; Arlt A; Schütze S; Schäfer H; Oestern S; Röder C; Ungefroren H; Lampe E; Heinrich M; Walczak H; Kalthoff H Oncogene; 2001 Jul; 20(31):4258-69. PubMed ID: 11464292 [TBL] [Abstract][Full Text] [Related]
14. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Lee KY; Park JS; Jee YK; Rosen GD Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088 [TBL] [Abstract][Full Text] [Related]
15. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S; Vega M; Garban H; Bonavida B Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892 [TBL] [Abstract][Full Text] [Related]
16. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes. Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160 [TBL] [Abstract][Full Text] [Related]
17. TRAIL upregulates decoy receptor 1 and mediates resistance to apoptosis in insulin-secreting INS-1 cells. Kang S; Park SY; Lee HJ; Yoo YH Biochem Biophys Res Commun; 2010 Jun; 396(3):731-5. PubMed ID: 20451496 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Nagaki M; Naiki T; Brenner DA; Osawa Y; Imose M; Hayashi H; Banno Y; Nakashima S; Moriwaki H Hepatology; 2000 Dec; 32(6):1272-9. PubMed ID: 11093734 [TBL] [Abstract][Full Text] [Related]
19. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-kappaB inhibition. Ammann JU; Haag C; Kasperczyk H; Debatin KM; Fulda S Int J Cancer; 2009 Mar; 124(6):1301-11. PubMed ID: 19065652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]